Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:40016772

A novel stemness-related lncRNA signature predicts prognosis, immune infiltration and drug sensitivity of clear cell renal cell carcinoma.

Journal of translational medicine · 2025 doi:10.1186/s12967-025-06251-6

Paper

partial

Experiment

partial

Data

partial

Analysis

absent

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:40016772
kind
science-record
content_hash
sha256:14183710cacc4afe4779993af3868c50bf37d1acdaac2b74c51a03d863215908
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T10:25:49Z
updated_at
2026-11-01T10:25:49Z
generator object · 3 fields
name
corpus-assay-engine
converter
sep_to_sci_v1
source_package_schema
urn:bntrg:sep:1.0.0
paper object · 10 fields
state
partial
title
A novel stemness-related lncRNA signature predicts prognosis, immune infiltration and drug sensitivity of clear cell renal cell carcinoma.
doi
10.1186/s12967-025-06251-6
pmid
40016772
authors
null
journal
Journal of translational medicine
year
2025
abstract
null
claims array · 1 item
[0] object · 6 fields
id
claim-1
statement
the headline numerical result the paper states for its main finding
kind
quantitative
state
complete
target object · 4 fields
value
6
unit
srlncrnas
tolerance
null
source
chars 2117-2179 of source sha256 03026cbe679b4a1f7eb958185e9d13783ffd626c7e0277a99bf21fd7fc123f39
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:40016772
locator
chars 2117-2179 of source sha256 03026cbe679b4a1f7eb958185e9d13783ffd626c7e0277a99bf21fd7fc123f39
quote
Six SRlncRNAs were used to construct the prognostic signature.
gaps array · 2 items
[0]
abstract
[1]
authors
experiment object · 8 fields
state
partial
objective
the headline numerical result the paper states for its main finding
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate and its interval from the source
kind
other
state
complete
blocked_on
null
description
The number a replication must land on, and the sentence it came from.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:40016772
outputs array · 1 item
[0]
the published estimate, its unit and its interval
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data behind the published result
kind
data-preparation
state
blocked
blocked_on
data:not_downloaded
description
The published result cannot be recomputed without the data the paper analysed.
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the source data with its provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the analysis programme
kind
analysis
state
blocked
blocked_on
no owned computational capability is bound to this experiment
description
Re-run the paper's analysis on the source data and produce the registered result. | SEP input not carried into the asset list: materials:the source data behind the published result in pmid:40016772
parameters object · 0 fields
inputs array · 0 items
outputs array · 1 item
[0]
the registered result
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 3 items
[0]
step:obtain_source_data blocked on data:not_downloaded
[1]
step:run_analysis blocked on no owned computational capability is bound to this experiment
[2]
step:run_analysis input 'materials:the source data behind the published result in pmid:40016772' does not resolve to a declared asset
data object · 3 fields
state
partial
assets array · 1 item
[0] object · 15 fields
id
source:pmid:40016772
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1186/s12967-025-06251-6
sha256
sha256:03026cbe679b4a1f7eb958185e9d13783ffd626c7e0277a99bf21fd7fc123f39
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1186/s12967-025-06251-6
version
null
note
Source read by the package builder: full_text.
structure object · 1 field
access_state
full_text
gaps array · 1 item
[0]
asset:source:pmid:40016772 not verified
analysis object · 4 fields
state
absent
methods array · 0 items
targets array · 0 items
gaps array · 2 items
[0]
method
[1]
targets
capability object · 3 fields
state
absent
requirements array · 0 items
gaps array · 1 item
[0]
capability
readiness object · 8 fields
state
partial
tier
null
blocked_on
null
axes object · 0 fields
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 1 item
[0]
source:pmid:40016772
steps array · 1 item
[0]
read_published_estimate
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 1 item
[0]
xml
capabilities array · 0 items
data_gaps array · 1 item
[0]
source:pmid:40016772
gaps array · 1 item
[0]
corpus_record_absent
review object · 5 fields
state
partial
machine_critique object · 7 fields
status
blocked
providers array · 1 item
[0] object · 7 fields
provider
minimax_alt
model
MiniMax-M3
prompt_version
full-text-reading-v1
prompt_hash
3060074df26371c8eabf61fd4ab39d366740588ffd4bc4f2a808cb6d3906140d
source_hash
03026cbe679b4a1f7eb958185e9d13783ffd626c7e0277a99bf21fd7fc123f39
raw_response_sha256
sha256:d51da2192d2a2e6da4c32bf70f8cc48a6565aa6676b367c5e020891e76f10831
raw_response_chars
54477
target_providers array · 2 items
[0] object · 8 fields
provider
minimax
model
MiniMax-M3.1-Flash
prompt_version
replication-target-v2
prompt_hash
775adb2bdebb8c6c3c5b4d7377453bbcd7bca8ac784bff75cfebebeb9e4da684
source_hash
03026cbe679b4a1f7eb958185e9d13783ffd626c7e0277a99bf21fd7fc123f39
raw_response
{"parent_value":6,"unit":"SRlncRNAs","evidence":"Six SRlncRNAs were used to construct the prognostic signature.","target_result":"The paper states that six SRlncRNAs were used to construct the prognostic signature.","number_stated":true}
reading object · 6 fields
parent_value
6
unit
SRlncRNAs
evidence
Six SRlncRNAs were used to construct the prognostic signature.
target_result
The paper states that six SRlncRNAs were used to construct the prognostic signature.
number_stated
true
source_locator
chars 2117-2179 of source sha256 03026cbe679b4a1f7eb958185e9d13783ffd626c7e0277a99bf21fd7fc123f39
recorded_at
2026-10-31T15:31:51.563582+00:00
[1] object · 8 fields
provider
minimax_alt
model
MiniMax-M3
prompt_version
replication-target-v2
prompt_hash
45e2805271f290ff2287e6ab50ebbd62d43c09865ce986f7bc2382d60f20b5e6
source_hash
03026cbe679b4a1f7eb958185e9d13783ffd626c7e0277a99bf21fd7fc123f39
raw_response
<think>We need answer JSON only, claims from source. Need identify single numerical result headline main finding registered target. Source has six SRlncRNAs signature, perhaps number stated is Six. Need determine "headline numerical result paper states for its main finding", likely signature comprised of 6 SRlncRNAs. The question expects extraction. Need exact contiguous quote containing number and attribution. Sentence: "Six SRlncRNAs were used to construct the prognostic signature." Headline numerical result maybe six lncRNAs. Need parent_value number 6, unit perhaps "SRlncRNAs" (paper prints? It doesn't print "6 SRlncRNAs", but "Six SRlncRNAs"). Unit must be unit paper prints. Could use "SRlncRNAs". Evidence exact quote. target_result perhaps "Six SRlncRNAs were used to construct the prognostic signature." number_stated true. But need inspect wording: Registered target = "the headline numerical result the paper states for its main finding." Main finding is novel stemness-related lncRNA signature. Numerical result in supplied source: Six SRlncRNAs used. Also 787 DEGs etc ancillary. The single headline likely six. Need report headline number only perhaps target_result should concise result perhaps "Six SRlncRNAs were used to construct the prognostic signature." They demand "Report headline number only" but schema target_result string. Perhaps set target_result "Six SRlncRNAs". Evidence full clause. unit "SRlncRNAs". Ensure exact quote. Parent value 6. Could there be actual headline result elsewhere omitted? Source appears abstract/results but detailed signature results absent. The numerical result likely number of genes (six). Need not overthink. Output valid JSON no markdown.</think> {"parent_value":6,"unit":"SRlncRNAs","evidence":"Six SRlncRNAs were used to construct the prognostic signature.","target_result":"Six SRlncRNAs were used to construct the prognostic signature.","number_stated":true}
reading object · 6 fields
parent_value
6
unit
SRlncRNAs
evidence
Six SRlncRNAs were used to construct the prognostic signature.
target_result
Six SRlncRNAs were used to construct the prognostic signature.
number_stated
true
source_locator
chars 2117-2179 of source sha256 03026cbe679b4a1f7eb958185e9d13783ffd626c7e0277a99bf21fd7fc123f39
recorded_at
2026-10-31T15:31:52.861157+00:00
agreement
false
disagreements array · 0 items
agreement_basis object · 2 fields
policy
decisive_fields
decisive_fields array · 4 items
[0]
work_type
[1]
number_stated
[2]
parent_value
[3]
unit
blinded
true
human_critique object · 5 fields
status
not_run
reviewer
null
signed_at
null
conflict_checked
false
commentary
null
stages array · 7 items
[0] object · 4 fields
key
target_materials
status
pending
reason
null
evidence
null
[1] object · 4 fields
key
independent_readings
status
blocked
reason
The independent readings are incomplete or disagree; the source evidence must resolve the difference.
evidence object · 1 field
provider_errors array · 1 item
[0] object · 4 fields
provider
minimax
model
MiniMax-M3.1-Flash
reason
a repository quotation is absent from the supplied text
raw_response
{ "target_result": "Six SRlncRNAs were used to construct the prognostic signature.", "work_type": "analysis_plus_physical_validation", "physical_methods": [ "single-cell RNA-seq (scRNA-seq)", "RT-qPCR", "in vitro experiments", "in vivo experiments" ], "analysis_methods": [ "RNA stemness scores (RNAss)", "weighted correlation network analysis (WGCNA)", "least absolute shrinkage and selection operator (LASSO)", "multivariate Cox regression", "gene set enrichment analysis (GSEA)", "immune infiltration assessment", "drug sensitivity prediction", "mutation landscape analysis", "Student's t-test", "Mann–Whitney U test", "limma" ], "statistical_method": "The least absolute shrinkage and selection operator (LASSO) in combination with multivariate Cox regression was selected as the optimal approach.", "method_evidence": "The least absolute shrinkage and selection operator (LASSO) in combination with multivariate Cox regression was selected as the optimal approach.", "repositories": [ { "repository": "The Cancer Genome Atlas (TCGA)", "accession": "TCGA-KIRC", "data_description": "Gene-expression and clinical data for the TCGA-KIRC training cohort, which was used to construct and assess the prognostic signature.", "evidence": "Gene-expression and clinical data were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Samples from TCGA-KIRC and GSE29609 cohorts were designated as the training and validation cohorts, respectively.", "publicly_downloadable": true }, { "repository": "Gene Expression Omnibus (GEO)", "accession": "GSE29609", "data_description": "Gene-expression and clinical data for the GSE29609 validation cohort, which was used to validate the prognostic signature.", "evidence": "Gene-expression and clinical data were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Samples from TCGA-KIRC and GSE29609 cohorts were designated as the training and validation cohorts, respectively.", "publicly_downloadable": true } ], "availability_statement": "The original data presented in this study are included within the article or its accompanying Supplementary Materials. Essential scripts and codes used for analysis are available on the Github website (https://github.com/pengdubjcancer/kirc_SRlncRNAs). For any further inquiries, please feel free to contact the corresponding author.", "data_on_request": true, "source_claims": [ "The study developed a prognostic signature consisting of six SRlncRNAs.", "LASSO combined with multivariate Cox regression was selected as the optimal modeling approach.", "TCGA-KIRC and GSE29609 were designated as the training and validation cohorts, respectively.", "The paper reports in vitro and in vivo validation of the findings." ], "missing_information": [ "The supplied text does not state a quantitative performance result for the prognostic signature, such as a hazard ratio, concordance index, AUC, or survival difference.", "The names of all six SRlncRNAs in the signature are not provided; only EMX2OS and LINC00944 are explicitly discussed.", "The regression coefficients and risk-score formula for the six-SRlncRNA signature are not provided.", "The paper does not explicitly state that TCGA-KIRC or GSE29609 can be accessed without an application, embargo, or request; public availability is inferred only from the statement that the data were downloaded from the named databases.", "The numerical criteria used to identify the signature's six SRlncRNAs are not reported in the supplied text." ], "evidence_spans": [ "Six SRlncRNAs were used to construct the prognostic signature.", "The least absolute shrinkage and selection operator (LASSO) in combination with multivariate Cox regression was selected as the optimal approach.", "Gene-expression and clinical data were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases.", "Samples from TCGA-KIRC and GSE29609 cohorts were designated as the training and validation cohorts, respectively.", "Expression and effects of SRlncRNAs in ccRCC were further corroborated through the utilization of single-cell RNA-seq (scRNA-seq), as well as in vitro and in vivo experiments.", "ScRNA-seq and RT-qPCR demonstrated the differential expression of SRlncRNAs between ccRCC tumors and normal tissues.", "In vitro and in vivo experiments demonstrated that downregulation of EMX2OS and LINC00944 affected the proliferation, migration, invasion, apoptosis, and metastasis of ccRCC cells.", "The original data presented in this study are included within the article or its accompanying Supplementary Materials. Essential scripts and codes used for analysis are available on the Github website (https://github.com/pengdubjcancer/kirc_SRlncRNAs). For any further inquiries, please feel free to contact the corresponding author." ] }
[2] object · 4 fields
key
source_resolution
status
pending
reason
null
evidence
null
[3] object · 4 fields
key
protocol_reconstruction
status
pending
reason
null
evidence
null
[4] object · 4 fields
key
control_execution
status
pending
reason
null
evidence
null
[5] object · 4 fields
key
control_comparison
status
pending
reason
null
evidence
null
[6] object · 4 fields
key
publication
status
pending
reason
null
evidence
null
gaps array · 2 items
[0]
review.human_critique
[1]
review.machine_critique.blocked
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 1 item
[0] object · 3 fields
id
package:53c07dd8eccc1336442a84e59b71fd88ecb6191cec853cb3e27939e0d7adf44c
type
sep_package
label
SEP v1 package for pmid:40016772
activities array · 1 item
[0] object · 4 fields
id
activity:conversion:pmid:40016772
type
conversion
used array · 1 item
[0]
package:53c07dd8eccc1336442a84e59b71fd88ecb6191cec853cb3e27939e0d7adf44c
agent
agent:corpus-assay-engine
agents array · 3 items
[0] object · 3 fields
id
agent:minimax
type
model
label
minimax
[1] object · 3 fields
id
agent:minimax_alt
type
model
label
minimax_alt
[2] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
source_run_id
run-20261023T122449232913
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
f3e8e2b9-6830-4a8d-a26a-00846e8574dc
parent_hash
53c07dd8eccc1336442a84e59b71fd88ecb6191cec853cb3e27939e0d7adf44c
fork_of
null
gaps array · 13 items
[0]
abstract
[1]
asset:source:pmid:40016772 not verified
[2]
authors
[3]
capability
[4]
corpus_record_absent
[5]
execution.not_run
[6]
method
[7]
review.human_critique
[8]
review.machine_critique.blocked
[9]
step:obtain_source_data blocked on data:not_downloaded
[10]
step:run_analysis blocked on no owned computational capability is bound to this experiment
[11]
step:run_analysis input 'materials:the source data behind the published result in pmid:40016772' does not resolve to a declared asset
[12]
targets
Complete file
{"sci_version": "1.0", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:40016772", "kind": "science-record", "revision": 1, "content_hash": "sha256:14183710cacc4afe4779993af3868c50bf37d1acdaac2b74c51a03d863215908", "created_at": "2026-11-01T10:25:49Z", "updated_at": "2026-11-01T10:25:49Z", "generator": {"name": "corpus-assay-engine", "converter": "sep_to_sci_v1", "source_package_schema": "urn:bntrg:sep:1.0.0"}, "paper": {"state": "partial", "title": "A novel stemness-related lncRNA signature predicts prognosis, immune infiltration and drug sensitivity of clear cell renal cell carcinoma.", "doi": "10.1186/s12967-025-06251-6", "pmid": "40016772", "authors": null, "journal": "Journal of translational medicine", "year": 2025, "abstract": null, "claims": [{"id": "claim-1", "statement": "the headline numerical result the paper states for its main finding", "kind": "quantitative", "state": "complete", "target": {"value": 6.0, "unit": "srlncrnas", "tolerance": null, "source": "chars 2117-2179 of source sha256 03026cbe679b4a1f7eb958185e9d13783ffd626c7e0277a99bf21fd7fc123f39"}, "evidence": [{"asset": "source:pmid:40016772", "locator": "chars 2117-2179 of source sha256 03026cbe679b4a1f7eb958185e9d13783ffd626c7e0277a99bf21fd7fc123f39", "quote": "Six SRlncRNAs were used to construct the prognostic signature."}]}], "gaps": ["abstract", "authors"]}, "experiment": {"state": "partial", "objective": "the headline numerical result the paper states for its main finding", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate and its interval from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The number a replication must land on, and the sentence it came from.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:40016772"], "outputs": ["the published estimate, its unit and its interval"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data behind the published result", "kind": "data-preparation", "state": "blocked", "blocked_on": "data:not_downloaded", "description": "The published result cannot be recomputed without the data the paper analysed.", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the source data with its provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the analysis programme", "kind": "analysis", "state": "blocked", "blocked_on": "no owned computational capability is bound to this experiment", "description": "Re-run the paper's analysis on the source data and produce the registered result. | SEP input not carried into the asset list: materials:the source data behind the published result in pmid:40016772", "duration_hours": null, "parameters": {}, "inputs": [], "outputs": ["the registered result"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:obtain_source_data blocked on data:not_downloaded", "step:run_analysis blocked on no owned computational capability is bound to this experiment", "step:run_analysis input 'materials:the source data behind the published result in pmid:40016772' does not resolve to a declared asset"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:40016772", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1186/s12967-025-06251-6", "sha256": "sha256:03026cbe679b4a1f7eb958185e9d13783ffd626c7e0277a99bf21fd7fc123f39", "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1186/s12967-025-06251-6", "version": null, "note": "Source read by the package builder: full_text.", "structure": {"access_state": "full_text"}}], "gaps": ["asset:source:pmid:40016772 not verified"]}, "analysis": {"state": "absent", "methods": [], "targets": [], "gaps": ["method", "targets"]}, "capability": {"state": "absent", "requirements": [], "gaps": ["capability"]}, "readiness": {"state": "partial", "tier": null, "blocking_axis": null, "blocked_on": null, "axes": {}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:40016772"], "steps": ["read_published_estimate"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": ["xml"], "capabilities": [], "data_gaps": ["source:pmid:40016772"]}, "gaps": ["corpus_record_absent"]}, "review": {"state": "partial", "machine_critique": {"status": "blocked", "providers": [{"provider": "minimax_alt", "model": "MiniMax-M3", "prompt_version": "full-text-reading-v1", "prompt_hash": "3060074df26371c8eabf61fd4ab39d366740588ffd4bc4f2a808cb6d3906140d", "source_hash": "03026cbe679b4a1f7eb958185e9d13783ffd626c7e0277a99bf21fd7fc123f39", "raw_response_sha256": "sha256:d51da2192d2a2e6da4c32bf70f8cc48a6565aa6676b367c5e020891e76f10831", "raw_response_chars": 54477}], "target_providers": [{"provider": "minimax", "model": "MiniMax-M3.1-Flash", "prompt_version": "replication-target-v2", "prompt_hash": "775adb2bdebb8c6c3c5b4d7377453bbcd7bca8ac784bff75cfebebeb9e4da684", "source_hash": "03026cbe679b4a1f7eb958185e9d13783ffd626c7e0277a99bf21fd7fc123f39", "raw_response": "{\"parent_value\":6,\"unit\":\"SRlncRNAs\",\"evidence\":\"Six SRlncRNAs were used to construct the prognostic signature.\",\"target_result\":\"The paper states that six SRlncRNAs were used to construct the prognostic signature.\",\"number_stated\":true}", "reading": {"parent_value": 6, "unit": "SRlncRNAs", "evidence": "Six SRlncRNAs were used to construct the prognostic signature.", "target_result": "The paper states that six SRlncRNAs were used to construct the prognostic signature.", "number_stated": true, "source_locator": "chars 2117-2179 of source sha256 03026cbe679b4a1f7eb958185e9d13783ffd626c7e0277a99bf21fd7fc123f39"}, "recorded_at": "2026-10-31T15:31:51.563582+00:00"}, {"provider": "minimax_alt", "model": "MiniMax-M3", "prompt_version": "replication-target-v2", "prompt_hash": "45e2805271f290ff2287e6ab50ebbd62d43c09865ce986f7bc2382d60f20b5e6", "source_hash": "03026cbe679b4a1f7eb958185e9d13783ffd626c7e0277a99bf21fd7fc123f39", "raw_response": "<think>We need answer JSON only, claims from source. Need identify single numerical result headline main finding registered target. Source has six SRlncRNAs signature, perhaps number stated is Six. Need determine \"headline numerical result paper states for its main finding\", likely signature comprised of 6 SRlncRNAs. The question expects extraction. Need exact contiguous quote containing number and attribution. Sentence: \"Six SRlncRNAs were used to construct the prognostic signature.\" Headline numerical result maybe six lncRNAs. Need parent_value number 6, unit perhaps \"SRlncRNAs\" (paper prints? It doesn't print \"6 SRlncRNAs\", but \"Six SRlncRNAs\"). Unit must be unit paper prints. Could use \"SRlncRNAs\". Evidence exact quote. target_result perhaps \"Six SRlncRNAs were used to construct the prognostic signature.\" number_stated true.\n\nBut need inspect wording: Registered target = \"the headline numerical result the paper states for its main finding.\" Main finding is novel stemness-related lncRNA signature. Numerical result in supplied source: Six SRlncRNAs used. Also 787 DEGs etc ancillary. The single headline likely six. Need report headline number only perhaps target_result should concise result perhaps \"Six SRlncRNAs were used to construct the prognostic signature.\" They demand \"Report headline number only\" but schema target_result string. Perhaps set target_result \"Six SRlncRNAs\". Evidence full clause. unit \"SRlncRNAs\". Ensure exact quote. Parent value 6.\n\nCould there be actual headline result elsewhere omitted? Source appears abstract/results but detailed signature results absent. The numerical result likely number of genes (six). Need not overthink. Output valid JSON no markdown.</think>\n\n{\"parent_value\":6,\"unit\":\"SRlncRNAs\",\"evidence\":\"Six SRlncRNAs were used to construct the prognostic signature.\",\"target_result\":\"Six SRlncRNAs were used to construct the prognostic signature.\",\"number_stated\":true}", "reading": {"parent_value": 6, "unit": "SRlncRNAs", "evidence": "Six SRlncRNAs were used to construct the prognostic signature.", "target_result": "Six SRlncRNAs were used to construct the prognostic signature.", "number_stated": true, "source_locator": "chars 2117-2179 of source sha256 03026cbe679b4a1f7eb958185e9d13783ffd626c7e0277a99bf21fd7fc123f39"}, "recorded_at": "2026-10-31T15:31:52.861157+00:00"}], "agreement": false, "disagreements": [], "agreement_basis": {"policy": "decisive_fields", "decisive_fields": ["work_type", "number_stated", "parent_value", "unit"]}, "blinded": true}, "human_critique": {"status": "not_run", "reviewer": null, "signed_at": null, "conflict_checked": false, "commentary": null}, "stages": [{"key": "target_materials", "status": "pending", "reason": null, "evidence": null}, {"key": "independent_readings", "status": "blocked", "reason": "The independent readings are incomplete or disagree; the source evidence must resolve the difference.", "evidence": {"provider_errors": [{"provider": "minimax", "model": "MiniMax-M3.1-Flash", "reason": "a repository quotation is absent from the supplied text", "raw_response": "{\n  \"target_result\": \"Six SRlncRNAs were used to construct the prognostic signature.\",\n  \"work_type\": \"analysis_plus_physical_validation\",\n  \"physical_methods\": [\n    \"single-cell RNA-seq (scRNA-seq)\",\n    \"RT-qPCR\",\n    \"in vitro experiments\",\n    \"in vivo experiments\"\n  ],\n  \"analysis_methods\": [\n    \"RNA stemness scores (RNAss)\",\n    \"weighted correlation network analysis (WGCNA)\",\n    \"least absolute shrinkage and selection operator (LASSO)\",\n    \"multivariate Cox regression\",\n    \"gene set enrichment analysis (GSEA)\",\n    \"immune infiltration assessment\",\n    \"drug sensitivity prediction\",\n    \"mutation landscape analysis\",\n    \"Student's t-test\",\n    \"Mann–Whitney U test\",\n    \"limma\"\n  ],\n  \"statistical_method\": \"The least absolute shrinkage and selection operator (LASSO) in combination with multivariate Cox regression was selected as the optimal approach.\",\n  \"method_evidence\": \"The least absolute shrinkage and selection operator (LASSO) in combination with multivariate Cox regression was selected as the optimal approach.\",\n  \"repositories\": [\n    {\n      \"repository\": \"The Cancer Genome Atlas (TCGA)\",\n      \"accession\": \"TCGA-KIRC\",\n      \"data_description\": \"Gene-expression and clinical data for the TCGA-KIRC training cohort, which was used to construct and assess the prognostic signature.\",\n      \"evidence\": \"Gene-expression and clinical data were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Samples from TCGA-KIRC and GSE29609 cohorts were designated as the training and validation cohorts, respectively.\",\n      \"publicly_downloadable\": true\n    },\n    {\n      \"repository\": \"Gene Expression Omnibus (GEO)\",\n      \"accession\": \"GSE29609\",\n      \"data_description\": \"Gene-expression and clinical data for the GSE29609 validation cohort, which was used to validate the prognostic signature.\",\n      \"evidence\": \"Gene-expression and clinical data were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Samples from TCGA-KIRC and GSE29609 cohorts were designated as the training and validation cohorts, respectively.\",\n      \"publicly_downloadable\": true\n    }\n  ],\n  \"availability_statement\": \"The original data presented in this study are included within the article or its accompanying Supplementary Materials. Essential scripts and codes used for analysis are available on the Github website (https://github.com/pengdubjcancer/kirc_SRlncRNAs). For any further inquiries, please feel free to contact the corresponding author.\",\n  \"data_on_request\": true,\n  \"source_claims\": [\n    \"The study developed a prognostic signature consisting of six SRlncRNAs.\",\n    \"LASSO combined with multivariate Cox regression was selected as the optimal modeling approach.\",\n    \"TCGA-KIRC and GSE29609 were designated as the training and validation cohorts, respectively.\",\n    \"The paper reports in vitro and in vivo validation of the findings.\"\n  ],\n  \"missing_information\": [\n    \"The supplied text does not state a quantitative performance result for the prognostic signature, such as a hazard ratio, concordance index, AUC, or survival difference.\",\n    \"The names of all six SRlncRNAs in the signature are not provided; only EMX2OS and LINC00944 are explicitly discussed.\",\n    \"The regression coefficients and risk-score formula for the six-SRlncRNA signature are not provided.\",\n    \"The paper does not explicitly state that TCGA-KIRC or GSE29609 can be accessed without an application, embargo, or request; public availability is inferred only from the statement that the data were downloaded from the named databases.\",\n    \"The numerical criteria used to identify the signature's six SRlncRNAs are not reported in the supplied text.\"\n  ],\n  \"evidence_spans\": [\n    \"Six SRlncRNAs were used to construct the prognostic signature.\",\n    \"The least absolute shrinkage and selection operator (LASSO) in combination with multivariate Cox regression was selected as the optimal approach.\",\n    \"Gene-expression and clinical data were downloaded from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases.\",\n    \"Samples from TCGA-KIRC and GSE29609 cohorts were designated as the training and validation cohorts, respectively.\",\n    \"Expression and effects of SRlncRNAs in ccRCC were further corroborated through the utilization of single-cell RNA-seq (scRNA-seq), as well as in vitro and in vivo experiments.\",\n    \"ScRNA-seq and RT-qPCR demonstrated the differential expression of SRlncRNAs between ccRCC tumors and normal tissues.\",\n    \"In vitro and in vivo experiments demonstrated that downregulation of EMX2OS and LINC00944 affected the proliferation, migration, invasion, apoptosis, and metastasis of ccRCC cells.\",\n    \"The original data presented in this study are included within the article or its accompanying Supplementary Materials. Essential scripts and codes used for analysis are available on the Github website (https://github.com/pengdubjcancer/kirc_SRlncRNAs). For any further inquiries, please feel free to contact the corresponding author.\"\n  ]\n}"}]}}, {"key": "source_resolution", "status": "pending", "reason": null, "evidence": null}, {"key": "protocol_reconstruction", "status": "pending", "reason": null, "evidence": null}, {"key": "control_execution", "status": "pending", "reason": null, "evidence": null}, {"key": "control_comparison", "status": "pending", "reason": null, "evidence": null}, {"key": "publication", "status": "pending", "reason": null, "evidence": null}], "gaps": ["review.human_critique", "review.machine_critique.blocked"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "package:53c07dd8eccc1336442a84e59b71fd88ecb6191cec853cb3e27939e0d7adf44c", "type": "sep_package", "label": "SEP v1 package for pmid:40016772"}], "activities": [{"id": "activity:conversion:pmid:40016772", "type": "conversion", "used": ["package:53c07dd8eccc1336442a84e59b71fd88ecb6191cec853cb3e27939e0d7adf44c"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:minimax", "type": "model", "label": "minimax"}, {"id": "agent:minimax_alt", "type": "model", "label": "minimax_alt"}, {"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}], "source_run_id": "run-20261023T122449232913", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "f3e8e2b9-6830-4a8d-a26a-00846e8574dc", "parent_hash": "53c07dd8eccc1336442a84e59b71fd88ecb6191cec853cb3e27939e0d7adf44c", "fork_of": null, "generation": 1}, "gaps": ["abstract", "asset:source:pmid:40016772 not verified", "authors", "capability", "corpus_record_absent", "execution.not_run", "method", "review.human_critique", "review.machine_critique.blocked", "step:obtain_source_data blocked on data:not_downloaded", "step:run_analysis blocked on no owned computational capability is bound to this experiment", "step:run_analysis input 'materials:the source data behind the published result in pmid:40016772' does not resolve to a declared asset", "targets"]}